257 related articles for article (PubMed ID: 7900583)
1. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
[TBL] [Abstract][Full Text] [Related]
2. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
3. Short TE proton MRS and neurofibromatosis type 1 intracranial lesions.
Norfray JF; Darling C; Byrd S; Ross BD; Schwalm C; Miller R; Tomita T
J Comput Assist Tomogr; 1999; 23(6):994-1003. PubMed ID: 10589584
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy.
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 May; 12(4):335-40. PubMed ID: 7546006
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1.
Alkan A; Sarac K; Kutlu R; Yakinci C; Sigirci A; Aslan M; Ozcan H; Yologlu S
Magn Reson Imaging; 2003 Nov; 21(9):1049-53. PubMed ID: 14684211
[TBL] [Abstract][Full Text] [Related]
6. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.
Cirak B; Horská A; Barker PB; Burger PC; Carson BS; Avellino AM
Childs Nerv Syst; 2005 May; 21(5):404-9. PubMed ID: 15372294
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of proton MR spectroscopy in the evaluation of temporal lobe epilepsy.
Thompson JE; Castillo M; Kwock L; Walters B; Beach R
AJR Am J Roentgenol; 1998 Mar; 170(3):771-6. PubMed ID: 9490972
[TBL] [Abstract][Full Text] [Related]
10. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
11. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
[TBL] [Abstract][Full Text] [Related]
12. Proton MR spectroscopy of cerebellitis.
Guerrini L; Belli G; Cellerini M; Nencini P; Mascalchi M
Magn Reson Imaging; 2002 Oct; 20(8):619-22. PubMed ID: 12467871
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
[TBL] [Abstract][Full Text] [Related]
14. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
15. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
16. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
17. Transsynaptic reduction in N-acetyl-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study.
Fulham MJ; Dietz MJ; Duyn JH; Shih HH; Alger JR; Di Chiro G
J Comput Assist Tomogr; 1994; 18(5):697-704. PubMed ID: 8089315
[TBL] [Abstract][Full Text] [Related]
18. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy in patients with seizure disorders.
Breiter SN; Arroyo S; Mathews VP; Lesser RP; Bryan RN; Barker PB
AJNR Am J Neuroradiol; 1994 Feb; 15(2):373-84. PubMed ID: 8192088
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors.
Chen CY; Lirng JF; Chan WP; Fang CL
J Formos Med Assoc; 2004 Jun; 103(6):448-58. PubMed ID: 15278190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
